Search
Previous Meetings
All of the meetings on this page took place in 2024. The most recent meetings are listed first. To view meetings from previous years, use the navigation menu.
Read moreRegistration
Register here
Individual registrationHybrid registration includes:
In-person access to the scientific and educational sessions of the meeting
Access to the virtual platform
Meeting materials
Coffee/tea breaks on February 6-8, 2025 and lunches on February 7-8, 2025
Access to the Welcome Reception
Access to the Poster Session(s) and…
EHA-SfPM Precision Medicine Meeting
EHA and SfPM (Society for Functional Precision Medicine) are proud to present the first joint meeting on Precision Medicine.
Read moreThrombocytopenias and Platelet Function Disorders
The SWG was established at the 2003 EHA Congress, which was held in Lyon, France. The group's original focus was thrombocytopenias, but it subsequently expanded its field of interest with the inclusion of platelet function disorders.
Read moreRed Cells and Iron
This SWG covers the clinical areas of inherited and acquired disorders of the erythrocyte and iron metabolism.
Read moreChairs and Members
ChairPaolo Gresele, Department of Medicine, Section of Internal and Cardiovascular Medicine, University of Perugia, Perugia (Italy)
Vice-ChairTo be announced.
SWG Educational Activities
MeetingsSession on thrombocytopenias and platelet function disordersAt the EHA 2023 Congress, we held a session on ‘Thrombocytopenias and platelet function disorders: Recent developments and perspectives in immune thrombocytopenia.
Read moreDiagnosis in hematological diseases: morphology and flow cytometry
This SWG is active in disseminating knowledge on advances in the diagnosis and follow-up by morphology and multiparameter flow-cytometry of malignant and non-malignant hematological diseases. These include morphology, digital morphology, and flow-cytometry (mass, imaging, and spectral flow cytometry included).
Read moreEuropean Research Initiative on CLL (ERIC)
ERIC is devoted to improving the outcome of patients with Chronic Lymphocytic Leukemia (CLL) and related diseases. The objectives of ERIC are to promote:
Research in all aspects of chronic lymphocytic leukemia and related diseases.
- «
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- »